Olaf Klingbeil
- Co-authors
- Christopher R. VakocTim D.D. SomervilleOsama E. DemerdashXiaoli WuJunwei ShiJoseph P. MilazzoYuhan HuangMikala Egeblad
- Topics
- Protein Degradation and Inhibitors (7 papers)Histone Deacetylase Inhibitors Research (4 papers)CRISPR and Genetic Engineering (3 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Olaf Klingbeil
17 papers receiving 684 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 425
- Oncology 316
- Epidemiology 152
- Cancer Research 118
- Pulmonary and Respiratory Medicine 70
Countries citing papers authored by Olaf Klingbeil
This map shows the geographic impact of Olaf Klingbeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Klingbeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Klingbeil more than expected).
Fields of papers citing papers by Olaf Klingbeil
This network shows the impact of papers produced by Olaf Klingbeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Klingbeil. The network helps show where Olaf Klingbeil may publish in the future.
Co-authorship network of co-authors of Olaf Klingbeil
This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Klingbeil. A scholar is included among the top collaborators of Olaf Klingbeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Klingbeil. Olaf Klingbeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 14 | |
| 4 | 8 | |
| 5 | 46 | |
| 6 | 22 | |
| 7 | 20 | |
| 8 | 4 | |
| 9 | 20 | |
| 10 | 20 | |
| 11 | 58 | |
| 12 | 40 | |
| 13 | 93 | |
| 14 | 256 | |
| 15 | 33 | |
| 16 | 41 | |
| 17 | 2 |
About Olaf Klingbeil
Olaf Klingbeil is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 17 papers that have together received 685 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Oncology (316 citations), Cancer Research (118 citations) and Molecular Biology (425 citations). Olaf Klingbeil has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Christopher R. Vakoc, Tim D.D. Somerville, Osama E. Demerdash, Xiaoli Wu, Junwei Shi, Joseph P. Milazzo, Yuhan Huang, Mikala Egeblad, Xue‐Yan He and David L. Spector. Their work appears in journals such as Nature, Nature Communications and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.